G Conzo1, A F Perna, A A Sinisi, A Palazzo, F Stanzione, C Della Pietra, A Livrea. 1. Department of Clinical and Experimental Internal Medicine F. Magrassi - A. Lanzara, IV Division of General Surgery and Endocrine Surgery, Second University of Naples, Italy. giovanni.conzo@unina2.it
Abstract
BACKGROUND: Subtotal parathyroidectomy (SP) and total parathyroidectomy (TP) with autotransplantation (TPai) are the most commonly adopted operations for the treatment of secondary hyperparathyroidism (2HPT). TP without autotransplantation had previously been confined to patients with advanced dialytic vintage, not eligible for kidney transplantation. Over the years, the procedure has gained more widespread use, but there is no precise knowledge on the immediate and long-term effects. METHODS: The authors analyzed the immediate and long-term results of TP without autotransplantation, that is after the systematic removal of at least four glands in 20 patients operated for 2HPT, which were compared with results from TPai in an equal number of cases. RESULTS: An improvement of the typical clinical symptoms was found in every patient undergoing surgery, and a significant reduction in intact PTH (iPTH) serum levels was achieved. Immediate normalization of iPTH level was observed in 11/20 TP cases, hypoparathyroidism in 4/20 and persistent HPT in 5/20 cases. One year of follow-up showed a slight increase in hypoparathyroidism, with 1/20 (5%) recurrence of the disease. One-year TPai results showed a similar percentage of euparathyroidism, as well as a higher longterm recurrence rate (4/20, 20%), although values do not reach statistical significance. CONCLUSIONS: TP may still be considered the operation of choice in patients with aggressive forms of 2HPT or of advanced dialytic vintage, with no access to renal transplantation, because of its low recurrence rate (5%). Post-operative aparathyroidism is rare, while hypoparathyroidism and hypocalcemia can be well controled by medical treatment.
BACKGROUND: Subtotal parathyroidectomy (SP) and total parathyroidectomy (TP) with autotransplantation (TPai) are the most commonly adopted operations for the treatment of secondary hyperparathyroidism (2HPT). TP without autotransplantation had previously been confined to patients with advanced dialytic vintage, not eligible for kidney transplantation. Over the years, the procedure has gained more widespread use, but there is no precise knowledge on the immediate and long-term effects. METHODS: The authors analyzed the immediate and long-term results of TP without autotransplantation, that is after the systematic removal of at least four glands in 20 patients operated for 2HPT, which were compared with results from TPai in an equal number of cases. RESULTS: An improvement of the typical clinical symptoms was found in every patient undergoing surgery, and a significant reduction in intact PTH (iPTH) serum levels was achieved. Immediate normalization of iPTH level was observed in 11/20 TP cases, hypoparathyroidism in 4/20 and persistent HPT in 5/20 cases. One year of follow-up showed a slight increase in hypoparathyroidism, with 1/20 (5%) recurrence of the disease. One-year TPai results showed a similar percentage of euparathyroidism, as well as a higher longterm recurrence rate (4/20, 20%), although values do not reach statistical significance. CONCLUSIONS: TP may still be considered the operation of choice in patients with aggressive forms of 2HPT or of advanced dialytic vintage, with no access to renal transplantation, because of its low recurrence rate (5%). Post-operative aparathyroidism is rare, while hypoparathyroidism and hypocalcemia can be well controled by medical treatment.
Authors: Miguel Echenique Elizondo; Francisco Javier Díaz-Aguirregoitia; José Antonio Amondarain; Fernando Vidaur Journal: World J Surg Date: 2005-11 Impact factor: 3.352
Authors: P A Decker; E P Cohen; K M Doffek; B A Ashley; M E Bienemann; Y R Zhu; M E Adams; S D Wilson; M J Demeure Journal: World J Surg Date: 2001-06 Impact factor: 3.352
Authors: Maria Grazia Esposito; Concetta Maria Cesare; Rosa Maria De Santo; Gennaro Cice; Alessandra F Perna; Eleonora Violetti; Giovanni Conzo; Giancarlo Bilancio; Salvatore Celsi; Filomena Annunziata; Simona Iannelli; Natale G De Santo; Massimo Cirillo; Antonio Livrea Journal: J Nephrol Date: 2008 Mar-Apr Impact factor: 3.902
Authors: Rosa Jofré; Juan Manuel López Gómez; Javier Menárguez; José Ramón Polo; Martin Guinsburg; Teresa Villaverde; Isabel Pérez Flores; Diana Carretero; Patrocinio Rodríguez Benitez; Rafael Pérez García Journal: Kidney Int Suppl Date: 2003-06 Impact factor: 10.545
Authors: Rajeev Narayan; Robert M Perkins; Elizabeth P Berbano; Christina M Yuan; Robert T Neff; Eric S Sawyers; Fred E Yeo; Gwenaelle M Vidal-Trecan; Kevin C Abbott Journal: Am J Kidney Dis Date: 2007-06 Impact factor: 8.860
Authors: Giovanni Conzo; Nicola Avenia; Giuseppe Bellastella; Giancarlo Candela; Annamaria de Bellis; Katherine Esposito; Daniela Pasquali; Andrea Polistena; Luigi Santini; Antonio Agostino Sinisi Journal: Endocrine Date: 2014-04-10 Impact factor: 3.633
Authors: G Conzo; A Perna; N Avenia; R M De Santo; C Della Pietra; A Palazzo; A A Sinisi; F Stanzione; L Santini Journal: Endocrine Date: 2012-03-16 Impact factor: 3.633
Authors: Giovanni Conzo; Alessandra F Perna; Salvatore Napolitano; Claudio Mauriello; Claudio Gambardella; Ersilia Satta; Giuseppe Ciancia; Giovanbattista Capasso; Luigi Santini Journal: J Med Case Rep Date: 2012-12-11